Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
Journal article
Kelly E. et al, (2023), J Infect
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
Journal article
Shaw RH. et al, (2023), J Infect, 86, 574 - 583
The effects of acute Methylene Blue administration on cerebral blood flow and metabolism in humans and rats
Journal article
Singh N. et al, (2023), Journal of Cerebral Blood Flow & Metabolism, 0271678X2311579 - 0271678X2311579
The effects of acute Methylene Blue administration on cerebral blood flow and metabolism in humans and rats
Conference paper
Singh N. et al, (2023), Journal of Cerebral Blood Flow and Metabolism
From bench to bedside: The mGluR5 system in people with and without Autism Spectrum Disorder and animal model systems.
Journal article
Carey C. et al, (2022), Transl Psychiatry, 12
The effects of acute Methylene Blue administration on cerebral blood flow and metabolism in humans and rats
Preprint
Singh N. et al, (2022)
The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls.
Journal article
Beck K. et al, (2022), J Psychopharmacol, 36, 1051 - 1060
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
Journal article
Marchevsky NG. et al, (2022), EBioMedicine, 81
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
Journal article
Li G. et al, (2022), Lancet, 399, 2212 - 2225
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Journal article
Stuart ASV. et al, (2022), Lancet, 399, 36 - 49
N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study
Journal article
Beck K. et al, (2021), Translational Psychiatry, 11
GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia.
Journal article
Kiemes A. et al, (2021), Neuropsychopharmacology
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.
Journal article
Feng S. et al, (2021), Nat Med, 27, 2032 - 2040
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Journal article
Flaxman A. et al, (2021), Lancet, 398, 981 - 990
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Journal article
Liu X. et al, (2021), Lancet, 398, 856 - 869
Resolving the cellular specificity of TSPO imaging in a rat model of peripherally-induced neuroinflammation.
Journal article
Vicente-Rodríguez M. et al, (2021), Brain Behav Immun, 96, 154 - 167
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
Journal article
Frater J. et al, (2021), Lancet HIV, 8, e474 - e485
A Modest Increase in 11C-PK11195-Positron Emission Tomography TSPO Binding in Depression Is Not Associated With Serum C-Reactive Protein or Body Mass Index.
Journal article
Schubert JJ. et al, (2021), Biol Psychiatry Cogn Neurosci Neuroimaging, 6, 716 - 724
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Journal article
Voysey M. et al, (2021), Lancet, 397, 881 - 891